Work

Use of bevacizumab to reduce the rate of oxaliplatin-induced thrombocytopenia and splenomegaly.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.4_suppl.564

Authors: Michael J. Overman, Binsah George, Karime Kalil, Renata Ferrarotto, Cathy Eng, Chris R. Garrett, Evelyn Loyer, Paulo Marcelo Hoff, Chusilp Charnsangavej, Scott Kopetz

Institutions: The University of Texas MD Anderson Cancer Center, Universidade de São Paulo, Instituto do Câncer do Estado de São Paulo, Hospital Sírio-Libanês

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2258426843

Cites:

Cited by: 1

Related to: 10